Radar · Healthcare in Seattle
Best Healthcare Companies in Seattle, United States
The 180 best Healthcare companies in Seattle, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Juno Therapeutics.
By Riya SenguptaFinancials
180companies tracked
$1.7Bdisclosed funding
0unicorns
43have raised
Ranked: Best Healthcare companies in Seattle
| # | Company | Disclosed funding | Last round | Employees | Founded | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Juno Therapeutics Global biopharmaceutical company discovering, developing, and delivering innovative medicines | $317M | 104 mo ago | 730 | 2013 | — | — | 1,436 patents Engineered T‑cell immunotherapies, CAR designs, gene‑editing, synthetic promoters, and biomarkers | — |
| 2 | Sibcr Facilitator of scientific research for veteran health improvement | $217M | 7 mo ago | 80 | 1989 | — | WordPress Block EditorWordPressMySQL+22 | — | — |
| 3 | vera whole health Vera Whole Health is a healthcare center that specializes in offering primary care services. | $126M | 58 mo ago | 312 | 2008 | — | SentryApple iCloud MailGoogle Workspace+18 | — | — |
| 4 | Just Biotherapeutics Designing technologies to accelerate biotherapeutic development and to reduce manufacturing costs | $124M | 96 mo ago | 79 | 2014 | — | — | 36 patents High‑throughput protein structure prediction, purification optimization, and physico‑chemical profiling. | — |
| 5 | Kineta Developing immune-modulating therapeutics and vaccine adjuvants for autoimmune and infectious diseases | $104M | 48 mo ago | 12 | 2008 | — | — | 217 patents Small-molecule PIKfyve inhibitors and heterocyclic kinase‑targeted therapeutics. | — |
| 6 | Vera Whole Health Provider of advanced primary care services including health and wellness support | $96M | 58 mo ago | 481 | 2008 | — | — | — | — |
| 7 | InduPro Provides science to manipulate protein interactions and explore new possibilities for treating patients 21Funding top 29%Tech bottom 40%Global bottom 36%Market bottom 22% All 4 signals ▾Fundingtop 29% Techbottom 40% Globalbottom 36% Marketbottom 22% Funding: Raised $85.0M across 1 rounds · 1 rounds over 2 yrs (0.5/yr) Tech: 20 technologies across 2/8 capability areas · Cloud: Cloudflare rank vs industry peers · Fliar Intelligence Index 21/100 | $85M | 6 mo ago | 34 | 2022 | — | WordPressMySQLPHP+17 | — | 1 partnership |
| 8 | Indapta Limited information available 55Funding top 31%Global bottom 48% All 2 signals ▾Fundingtop 31% Globalbottom 48% Funding: Raised $72.8M across 3 rounds · 3 rounds over 7 yrs (0.4/yr) Global: Investors from 2 countries beyond United States rank vs industry peers · Fliar Intelligence Index 55/100 | $73M | 18 mo ago | 14 | 2016 | — | — | — | — |
| 9 | Tenpoint Therapeutics Developer of engineered cell-based therapeutics to restore vision 50Funding top 23%Talent top 23%Moat top 31%Growth top 33% All 8 signals ▾Fundingtop 23% Talenttop 23% Moattop 31% Growthtop 33% Techtop 49% Newstop 49% Globalbottom 39% Marketbottom 26% Funding: Raised $70.0M across 3 rounds · 3 rounds over 3 yrs (1.0/yr) Talent: 8 named leaders on record · 8 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 50/100 | $70M | 4 mo ago | 14 | 2020 | Jose Sahel Co-Founder | WordPressMySQLMariaDB+25 | — | — |
| 10 | Impel Pharmaceuticals Provider of trans-formative therapy development and commercialisation services | $68M | 90 mo ago | 160 | 2008 | — | WordPressApple iCloud MailMicrosoft 365+19 | — | — |
| 11 | Omeros Developing drugs for inflammation, coagulopathies, and disorders of the central nervous system | $63M | 14 mo ago | 276 276 → 224 (-19%) | 1994 | Greg Demopulos Chairman and CEO | DrupalApple iCloud MailPHP+26 | 1,583 patents Therapeutic MASP-1/2/3 inhibitors and complement‑targeting antibodies for disease treatment | — |
| 12 | Rippl Care Provider of mental healthcare services for older people 40Funding top 25%Growth top 32%Tech top 45%Talent bottom 49% All 6 signals ▾Fundingtop 25% Growthtop 32% Techtop 45% Talentbottom 49% Globalbottom 32% Marketbottom 21% Funding: Raised $55.0M across 2 rounds · 2 rounds over 4 yrs (0.5/yr) Growth: Web rank 50,000,000 → 10,000,000 YoY · 1 acquisition/expansion move in 24 mo rank vs industry peers · Fliar Intelligence Index 40/100 | $55M | 20 mo ago | 36 | 2021 | Kris Engskov Co-Founder & CEO | Cart FunctionalitySquarespace CommerceSquarespace+20 | — | — |
| 13 | Bulletproof Retailer of coffee, supplements, MCT oil, mix-ins, collagen, and protein bars | $44M | 36 mo ago | 90 | 2013 | Dave Asprey Founder | Cart FunctionalityShopifySentry+43 | — | — |
| 14 | Xcyte Therapeutics T-cell based therapy for cancer and infectious diseases | $28M | 310 mo ago | 5 | 1996 | Ronald J Berenson CEO | — | — | — |
| 15 | Have a Heart Chain of medical cannabis dispensaries | $25M | 93 mo ago | 400 | 2011 | Ryan Kunkel Owner / Founder | WordPressMySQLPHP+27 | — | — |
| 16 | Etubics Therapeutic vaccines for cancer | $23M | 141 mo ago | 14 | 2005 | — | — | 160 patents Manufacturing adenoviral vectors for multi‑vaccine and cancer immunotherapy applications | — |
| 17 | MediQuest Therapeutics Biopharmaceutical company developing therapeutics to treat inflammatory and infectious diseases | $22M | 187 mo ago | 13 | 2002 | — | — | — | — |
| 18 | Kline Galland Standalone senior living center | $21M | 174 mo ago | 230 | 1841 | Jeffrey Cohen CEO | WordPress Block EditorWordPressMySQL+29 | — | — |
| 19 | Empower Clinics Provider of clinics empowerment, cannabis based products, and related compliance support services | $19M | 34 mo ago | 12 | 2013 | Steven McAuley Chairman & CEO | — | — | — |
| 20 | Receptor Life Sciences Manufacturer of cannabinoid medicines | $17M | 50 mo ago | 10 | 2015 | Traci Carman Founder | — | — | — |
| 21 | Kevala Provider of staffing services to healthcare management | $16M | 52 mo ago | 49 | 2020 | Todd Owens Founder & CEO | ErlangElixirPhoenix Framework+17 | 3 patents Predictive modeling of localized carbon intensity for electrical power grids | — |
| 22 | AdaptX Provider of clinical management solutions | $16M | 9 mo ago | 38 | 2016 | Warren Ratliff CEO | — | — | — |
| 23 | Circulate Provider of therapeutic plasma exchange treatments for age-related diseases and conditions | $13M | 6 mo ago | — | 2021 | Brad Y CEO @ Co-Founder | WordPressMySQLPHP+20 | — | 1 partnership |
| 24 | Docklight Manufacturer of CBD infused chocolates and wellness shots | $11M | 62 mo ago | 17 | 2018 | — | — | — | — |
| 25 | Singletto Developer of pathogen-destroying singlet oxygen solutions and light activated dyes 55Funding top 29%Patents top 37%Innovation top 40%Moat bottom 49% All 7 signals ▾Fundingtop 29% Patentstop 37% Innovationtop 40% Moatbottom 49% Talentbottom 49% Marketbottom 45% Globalbottom 29% Funding: Raised $10.9M across 5 rounds · 5 rounds over 5 yrs (1.0/yr) Patents: 13 patents matched (strict assignee match) · 13 filings since 2022 vs 0 in 2017-21 rank vs industry peers · Fliar Intelligence Index 55/100 | $11M | 3 mo ago | 12 | 2020 | Thomas Lendvay Co-Founder | — | 13 patents Antimicrobial disinfection and protective coatings for PPE, skin, air and surfaces | — |
| 26 | Auderenow Provider of AI-powered digital health solutions for improved healthcare decision-making | $9M | 38 mo ago | 45 | 2018 | Tracy Rodgers CEO and Founder | Cart FunctionalitySquarespace CommerceSquarespace+21 | — | 1 partnership |
| 27 | Big Bold Health Manufacturer of ayurveda based medicines | $8M | 17 mo ago | 14 | 2018 | Jeffrey Bland Founder & President | Cart FunctionalityShopifyZoho+31 | — | — |
| 28 | Salish Bioscience Provider of cancer detection and screening services | $7M | 50 mo ago | 4 | 2021 | Christopher Raymond Co-Founder & Chief Scientific Officer | — | — | — |
| 29 | PharmID Provider of verification services for pharmaceutical products | $6M | 100 mo ago | 10 | 2017 | — | — | — | — |
| 30 | Goodbill Provider of hospital bill transaction, identifying errors, and managing services | $5M | 26 mo ago | 11 | 2003 | Patrick Haig Co-founder | RubyD3Plotly+19 | — | — |
| 31 | Mindful Nourishment Standalone wellness center | $5M | 23 mo ago | — | 2020 | Nabila Bhimji Owner | — | — | — |
| 32 | Nuun Hydration Manufacturer of electrolyte tablets and hydration powders | $3M | 103 mo ago | 75 | 2004 | — | Cart FunctionalityShopifyShogun Page Builder+42 | — | — |
| 33 | Key Proteo Project focused on preemptive treatment for genetic diseases for newborn babies | $3M | 37 mo ago | 4 | 2019 | Sihoun Hahn Founder & CEO | — | — | — |
| 34 | Accium BioSciences Accelerator Mass Spectrometry (AMS) services for preclinical and clinical studies | $3M | 245 mo ago | 15 | 2004 | Glenn Kawasaki CEO & President | — | — | — |
| 35 | Wikileaf Manufacturer and supplier of cannabis based medicine | $3M | 63 mo ago | 30 | 2014 | — | — | — | — |
| 36 | Nanodropper Provider of volume reducing adaptors for eyedrop bottles. | $3M | 62 mo ago | 11 | 2018 | Allisa Song Co-Founder & CEO | WordPress Block EditorDiviCart Functionality+19 | 26 patents Micro‑volume ophthalmic drug delivery adapters and spray cartridges for eye drop bottles | 1 launch |
| 37 | Blood Cell Storage Manufacturer of pH fluorescent sensor products | $2M | 169 mo ago | — | 1999 | Russ Aldrich CEO | — | 58 patents Fluorescent sensor systems for monitoring chemical conditions in sterile blood cell storage | — |
| 38 | Antara Health Provider of AI based healthcare navigation services | $2M | 64 mo ago | 61 | 2019 | Kebba Jobarteh Co-Founder & CEO | WebflowYouTubeIntercom+10 | — | — |
| 39 | SōRSE Manufacturer of cannabis edible oil products | $2M | 48 mo ago | 39 | 2016 | — | WordPressMySQLPHP+29 | — | — |
| 40 | Glidance Provider of virtualization and automation software for consumers, businesses, and service providers | $2M | 23 mo ago | 3 | — | — | WordPressMySQLPHP+18 | — | 1 job opening · 1 launch |
| 41 | OLEO Manufacturer of cannaboid drink mixes | $2M | 82 mo ago | 1 | 2015 | Arooshi Dahiya Founder | — | 6 patents Lipid feedstock pretreatment: degumming and adsorptive bleaching/drying for biofuel production | — |
| 42 | Centred Wellness Standalone wellness center | $1M | 74 mo ago | 10 | 2020 | Elie Camoro Co-Founder | — | — | — |
| 43 | EnTox Provider of analytical tools for research and drug development | $1M | 86 mo ago | — | 2018 | Ian Sweet CEO | — | 4 patents Soluble clinoptilolite fragments for pharma, nutraceutical and environmental remediation applications. | — |
| 44 | Gmj Technologies Manufacturer of protein characterization tools | $996K | 64 mo ago | — | 2018 | Tosin Dada CEO | — | — | — |
| 45 | Seattle Bouldering Project Fitness center | $850K | 182 mo ago | 53 | 2010 | Christopher Potts Co-Founder | — | — | — |
| 46 | Diego Pellicer Publisher and retailer of luxury coffee table books and home objects | $825K | 95 mo ago | — | 2011 | Ron Throgmartin CEO | — | — | — |
| 47 | Ora Biomedical Developer of AI-driven platform for high-throughput drug screening in live animals | $720K | 21 mo ago | 3 | 2022 | Mitchell Lee Co-Founder & CEO | WordPressMySQLPHP+30 | — | 1 partnership · 1 expansion |
| 48 | CathConnect Project focused on healthcare innovation program | $208K | 35 mo ago | 7 | 2023 | Michael Malone Co-Founder | — | — | — |
| 49 | Equipt Health Provides home based sleep apnea treatment services | $125K | 60 mo ago | — | 2021 | Rebecca Weisinger Co-Founder | — | — | — |
Top 12 Healthcare companies in Seattle
#1
Funding Raised · Seattle, Washington · founded 1989 · 80 employees$217.5Mraised▾
Funding Raised · Seattle, Washington · founded 1989 · 80 employees
Facilitator of scientific research for veteran health improvement. This entity partners with scientists and research organizations to support medical research benefiting veterans. Services include grant and contract portfolio management, fostering collaboration through events and lecture series, and enabling investigators to focus on scientific advancements. The organization aims to improve the health and well-being of veterans through facilitated research and collaboration.
Funding rounds
- Nov 2025Grant (prize money)$1.9M
- Sep 2025Grant (prize money)$803.8K
- Jul 2025Grant (prize money)$1.4M
- Jul 2025Grant (prize money)$545.8K
Investors
HHS, Military Health
Tech stack
Advanced Custom FieldsAll In One SeoDreamhostGoogle AnalyticsIsotopeJquery
#2
Series B · Seattle, Washington · founded 2020 · 14 employees$70Mraised▾
Series B · Seattle, Washington · founded 2020 · 14 employees
Developer of engineered cell-based therapeutics to restore vision. The company is advancing cell-based therapies and in vivo reprogramming to restore vision loss caused by the deterioration of functional tissue for people with degenerative ocular diseases.
Fliar Intelligence Index™ 50how this company ranks against its industry peers
Funding
top 23%Talent
top 23%Moat
top 31%Growth
top 33%Tech
top 49%News
top 49%Funding: Raised $70.0M across 3 rounds · 3 rounds over 3 yrs (1.0/yr) · Last round Series B (Jan 2026)
Talent: 8 named leaders on record · 8 C-suite/founder profiles curated
Moat: Editorial + unicorn rating 8/10 · Soonicorn · 10 curated direct competitors tracked
Funding rounds
- Jan 2026Conventional Debt$150M
- Jan 2026Series B$85M
- Jul 2023Series A$70M
- 2021Seed—
Founders & team
Investors
British Patient Capital, F-Prime Capital, Sofinnova Partners, Qiming, Eight Roads Ventures, UCL Technology Fund
Tech stack
AccessibeAnime.JsCookieyesCore-JsElementorFastly
#3
Series A · Seattle, Washington · founded 2022 · 34 employees$85Mraised▾
Series A · Seattle, Washington · founded 2022 · 34 employees
InduPro is a biotechnology company that focuses on bringing proteins on the cell surface closer together, manipulating their interactions to open up new possibilities for treating various conditions. They have a multidisciplinary team with backgrounds in pharma, academia, and biotech, and they are dedicated to impacting patients' lives through innovative drug development.
Fliar Intelligence Index™ 21how this company ranks against its industry peers
Funding
top 29%Tech
bottom 40%Global
bottom 36%Market
bottom 22%Funding: Raised $85.0M across 1 rounds · 1 rounds over 2 yrs (0.5/yr) · Last round Series A (Dec 2025)
Tech: 20 technologies across 2/8 capability areas · Cloud: Cloudflare · Security: Cloudflare Bot Management, Http/3
Global: Investors from 1 country beyond United States
Audience (LinkedIn): 4k LinkedIn followers — 5.9% of this cohort's audience
Activity (LinkedIn): 2 partnerships (incl. Lilly) announced in 12 mo
Funding rounds
- Dec 2025Series A—
- Jun 2024Series A$85M
Investors
The Column Group, Vida Ventures, MRLV, Emerson Collective, Euclidean Capital, Sanofi
Tech stack
CdnjsCloudflareCloudflare Bot ManagementD3Fullpage.JsGodaddy
#4
Series B · Seattle, Washington · founded 2020 · 12 employees$10.9Mraised▾
Series B · Seattle, Washington · founded 2020 · 12 employees
Developer of pathogen-destroying singlet oxygen solutions and light activated dyes
Fliar Intelligence Index™ 55how this company ranks against its industry peers
Funding
top 29%Patents
top 37%Innovation
top 40%Moat
bottom 49%Talent
bottom 49%Market
bottom 45%Funding: Raised $10.9M across 5 rounds · 5 rounds over 5 yrs (1.0/yr) · Last round Conventional Debt (Mar 2026)
Patents: 13 patents matched (strict assignee match) · 13 filings since 2022 vs 0 in 2017-21 · Latest publication 2025
Innovation: 13 patents (top 61% of patent-holders) · 13 filings since 2022 vs 0 in 2017-21
Audience (LinkedIn): 271 LinkedIn followers
Hiring (LinkedIn): 1 hiring post in 12 mo (public) · hiring: Director of Growth Enablement & Communications
Activity (LinkedIn): 1 product launches announced in 12 mo
Funding rounds
- Mar 2026Conventional Debt$100K
- Apr 2025Series B$10.5M
- Jan 2024Conventional Debt$65K
- May 2023Conventional Debt$200K
Founders & team
#5
Public · Seattle, Washington · founded 1994 · 276 employees$63.3Mraised▾
Public · Seattle, Washington · founded 1994 · 276 employees
Omeros is a biopharmaceutical company committed to discovering, developing and commercializing both small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. Derived from its proprietary PharmacoSurgery platform, the company’s first drug product, Omidria (phenylephrine and ketorolac injection) has been approved by the FDA for use during cataract surgery or intraocular lens (IOL) replacement to maintain pupil size by preventing intraoperative miosis (pupil constriction) and to reduce postoperative ocular pain. In the European Union, the European Commission (EC) has approved Omidria for use in cataract surgery and lens replacement procedures to maintain mydriasis (pupil dilation), prevent miosis (pupil constriction), and to reduce postoperative eye pain. Omeros has five clinical-stage development programs focused on: complement-related thrombotic microangiopathies; Huntington’s disease, schizophrenia, and cognitive impairment; addictive and compulsive disorders; and preventing problems associated with urologic surgical procedures. In addition, Omeros has a proprietary GPC
LinkedIn Pulse recent public activity · Jul 2026
Audience: 13k LinkedIn followers — 17.2% of this cohort's audience
Activity: 1 product launches · 1 partnerships (incl. Omeros) announced in 12 mo
Funding rounds
- Apr 2025Grant (prize money)$6.7M
- Mar 2025Grant (prize money)$6.7M
- Apr 2023Grant (prize money)$6.7M
- Nov 2018Post IPO$210M
Founders & team
Investors
Aravis, Arch Venture Partners, GCM Grosvenor, Novartis Venture Fund, Southern Cross Group, Trevi Health Ventures
Tech stack
Animate.CssApple Icloud MailCloudflareCloudflare Browser InsightsCookiebotDocusign
#6
Seed · Seattle, Washington · founded 2021$13Mraised▾
Seed · Seattle, Washington · founded 2021
Provider of therapeutic plasma exchange treatments for age-related diseases and conditions. The company delivers fully managed solutions for clinics and doctor's offices, offering treatments without capital investment in technology or staffing. The treatment removes inflammatory and age-accelerating substances from the bloodstream. The company's technology is FDA cleared and backed by scientific research.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 1k LinkedIn followers
Activity: 1 partnerships (incl. Reborne Longevity) announced in 12 mo
Funding rounds
- Dec 2025Seed—
- Jun 2025Seed$13M
Founders & team
Investors
Khosla Ventures, Seaside Ventures, CSC Upshot Ventures, Scrum Ventures
Tech stack
CloudflareCloudflare Bot ManagementCookieyesDiviGoogle AnalyticsGoogle Font Api
#7
Series A · Seattle, Washington · founded 2016 · 38 employees$16Mraised▾
Series A · Seattle, Washington · founded 2016 · 38 employees
Provider of clinical management solutions
LinkedIn Pulse recent public activity · Jul 2026
Audience: 2k LinkedIn followers — 2.1% of this cohort's audience
Hiring: 1 hiring post in 12 mo (public) · hiring: Clinical Impact Manager
Activity: 1 partnerships (incl. Deloitte) announced in 12 mo
Funding rounds
- Sep 2025Series A$2.7M
- Aug 2025Series A$450K
- Sep 2023Series A$10M
- May 2021Series A$6M
Founders & team
Investors
Cercano Management, Memorial Hermann, Founders' Co-op, Fortson, Star Equity Fund, Morningside
#8
Series A · Seattle, Washington · founded 2016 · 14 employees$72.8Mraised▾
Series A · Seattle, Washington · founded 2016 · 14 employees
Limited information available
Fliar Intelligence Index™ 55how this company ranks against its industry peers
Funding
top 31%Global
bottom 48%Funding: Raised $72.8M across 3 rounds · 3 rounds over 7 yrs (0.4/yr) · Last round Series A (Dec 2024)
Global: Investors from 2 countries beyond United States
Audience (LinkedIn): 2k LinkedIn followers — 2.8% of this cohort's audience
Funding rounds
- Dec 2024Series A$22.5M
- Feb 2022Series A$50M
- May 2019Grant (prize money)$300K
Investors
RA Capital Management, Leaps by Bayer, Myeloma Investment Fund, Vertex Ventures HC, Pontifax, HHS
#9
Acquired · Seattle, Washington · founded 2021 · 36 employees$55Mraised▾
Acquired · Seattle, Washington · founded 2021 · 36 employees
Provider of mental healthcare services for older people
Fliar Intelligence Index™ 40how this company ranks against its industry peers
Funding
top 25%Growth
top 32%Tech
top 45%Talent
bottom 49%Global
bottom 32%Market
bottom 21%Funding: Raised $55.0M across 2 rounds · 2 rounds over 4 yrs (0.5/yr) · Last round Series A (Oct 2024)
Growth: Web rank 50,000,000 → 10,000,000 YoY · 1 acquisition/expansion move in 24 mo · Fresh capital in last 24 mo
Tech: 27 technologies across 4/8 capability areas · Cloud: Amazon Cloudfront, Amazon Web Services · Observability: Sentry
Audience (LinkedIn): 10k LinkedIn followers — 13.2% of this cohort's audience
Activity (LinkedIn): 1 partnerships (incl. forward-thinking payors) announced in 12 mo
Funding rounds
- Oct 2024Series A$23M
- Sep 2022Seed$32M
Founders & team
Investors
Kin Ventures, Arch Venture Partners, General Catalyst, Google Ventures, F-Prime Capital, Mass General Brigham Ventures
Tech stack
Amazon CloudfrontAmazon Web ServicesAngularCart FunctionalityCloudflareCloudinary
#10
Series B · Seattle, Washington · founded 2018 · 14 employees$7.7Mraised▾
Series B · Seattle, Washington · founded 2018 · 14 employees
Manufacturer of ayurveda based medicines
LinkedIn Pulse recent public activity · Jul 2026
Audience: 2k LinkedIn followers — 3.1% of this cohort's audience
Activity: 1 awards announced in 12 mo
Funding rounds
- Jan 2025Series B—
- Jul 2024Series B$3M
- Jul 2023Series A$750K
- Mar 2022Series A$4M
Founders & team
Investors
S2G Investments, Starshot Ventures, Andas
Tech stack
Amazon PayApple PayBluehostBuy With PrimeCart FunctionalityCdnjs
#11
Series A · Seattle, Washington · founded 2020$5Mraised▾
Series A · Seattle, Washington · founded 2020
Standalone wellness center
Founders & team
#12
Acquired · Seattle, Washington · founded 2008 · 12 employees$103.5Mraised▾
Acquired · Seattle, Washington · founded 2008 · 12 employees
Kineta is focused on developing immune-modulating therapeutics and vaccine adjuvants for autoimmune and infectious diseases. Autoimmune disease pipeline includes dalazitide in clinical trial phase 1B for Lupus, Psoriasis, Psoriatic Arthritis, RA, MS, Vasculitis, IBD, Asthma, AD, Type 1 diabetes (T1D). Antiviral pipeline includes compounds of preclinical categories innate-immune antivirals, vaccine adjuvants and direct-acting antivirals all of which discovered using its proprietary aviid antiviral discovery platform. It also has a chronic pain candidate in preclinical stage for diabetic nephropathy and traumatic injury
Funding rounds
- Jun 2022Series D$17.4M
- Feb 2022Series D$2.4M
- Jun 2021Series D$1.2M
- Jun 2021Series D$17.4M
Investors
NIAID, Cheongbo Industrial, Wellcome, The Iacocca Family Foundation, Keiretsu Forum Seattle, HHS
Tech stack
WordpressMysqlPhpParticles.JsAnimate.CssWpforms
Funding & investor landscape
$1.7Btotal disclosed funding
51companies funded
267disclosed rounds
0rounds last 90 days
Most active investors
Notable founders
Jose Sahel
Co-Founder · Tenpoint Therapeutics
Lyndon Cruz
Co-Founder · Tenpoint Therapeutics
Thomas Lendvay
Co-Founder · Singletto
Greg Demopulos
Chairman and CEO · Omeros
Brad Y
CEO @ Co-Founder · Circulate
Brad Younggren
CEO @ Co-Founder · Circulate
Warren Ratliff
CEO · AdaptX
Kris Engskov
Co-Founder & CEO · Rippl Care
Jeffrey Bland
Founder & President · Big Bold Health
Nabila Bhimji
Owner · Mindful Nourishment
Dave Asprey
Founder · Bulletproof
Steven McAuley
Chairman & CEO · Empower Clinics
Prism market signals · United States · country-scoped Prism corpus, 13,358,462 docs
Market landscape — 10 sub-themes by coverage
Share of Healthcare coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
Common questions
How many Healthcare companies are there in Seattle, United States?
Radar tracks 180 indexable Healthcare companies headquartered in Seattle, United States that meet our profile-completeness bar.
What is the total funding raised by Healthcare companies in Seattle, United States?
The Healthcare companies in Seattle, United States on this list have raised a combined $1.7B in disclosed equity funding across 51 funded companies.
Which is the highest-funded Healthcare company in Seattle, United States?
Juno Therapeutics is the highest-funded Healthcare company in Seattle, United States, with $316.7M in disclosed equity funding.
How many Healthcare companies in Seattle, United States are funded?
51 of the 180 Healthcare companies in Seattle, United States on this list have disclosed at least one equity funding round.
How many Healthcare unicorns are there in Seattle, United States?
None of the Healthcare companies in Seattle, United States on this list currently has a disclosed valuation of $1B or more.
Who are the top investors in Seattle, United States Healthcare companies?
The most active investors in Seattle, United States Healthcare companies on this list include HHS, Arch Venture Partners, Washington Research Foundation, Vulcan Capital, 424 Capital.
Riya SenguptaFinancials
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.